Complete financial analysis of Redcare Pharmacy NV (SHPPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Redcare Pharmacy NV, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Gel S.p.A. (GEL.MI) Income Statement Analysis – Financial Results
- Home Capital Group Inc. (HCG.TO) Income Statement Analysis – Financial Results
- Directa Plus Plc (DCTA.L) Income Statement Analysis – Financial Results
- ABL Bio Inc. (298380.KQ) Income Statement Analysis – Financial Results
- Revival Gold Inc. (RVLGF) Income Statement Analysis – Financial Results
Redcare Pharmacy NV (SHPPF)
About Redcare Pharmacy NV
Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.80B | 1.20B | 1.06B | 968.06M | 701.01M | 539.71M | 283.99M | 177.39M | 125.58M | 84.67M | 55.29M |
| Cost of Revenue | 1.36B | 872.57M | 793.79M | 748.53M | 563.33M | 440.39M | 226.41M | 141.11M | 99.84M | 66.64M | 42.55M |
| Gross Profit | 440.38M | 331.79M | 266.53M | 219.53M | 137.68M | 99.32M | 57.58M | 36.28M | 25.74M | 18.04M | 12.75M |
| Gross Profit Ratio | 24.48% | 27.55% | 25.14% | 22.68% | 19.64% | 18.40% | 20.28% | 20.45% | 20.49% | 21.30% | 23.05% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 33.00M | 26.51M | 21.25M | 19.39M | 15.51M | 13.79M | 8.98M | 4.61M | 4.14M | 1.92M | 1.24M |
| Selling & Marketing | 234.44M | 217.73M | 175.63M | 125.85M | 93.20M | 64.71M | 46.66M | 28.69M | 20.89M | 13.07M | 8.36M |
| SG&A | 267.44M | 244.24M | 196.88M | 145.24M | 108.71M | 78.50M | 55.64M | 33.30M | 25.03M | 15.00M | 9.59M |
| Other Expenses | 190.24M | 0.00 | 0.00 | 65.00K | 136.00K | -4.00K | 3.02M | 2.20M | 1.32M | 928.00K | 673.00K |
| Operating Expenses | 457.68M | 401.11M | 332.39M | 220.46M | 171.86M | 128.24M | 79.80M | 50.13M | 35.87M | 23.01M | 15.30M |
| Cost & Expenses | 1.82B | 1.27B | 1.13B | 968.99M | 735.19M | 568.64M | 306.20M | 191.23M | 135.71M | 89.65M | 57.84M |
| Interest Income | 4.61M | 274.00K | 28.00K | 93.00K | 112.00K | 24.00K | 40.00K | 17.00K | 593.00K | 0.00 | 0.00 |
| Interest Expense | 8.00M | 8.50M | 8.57M | 10.76M | 7.48M | 3.44M | 2.25M | 9.34M | 2.28M | 826.00K | 839.00K |
| Depreciation & Amortization | 57.29M | 39.51M | 26.96M | 16.06M | 7.86M | 7.43M | 3.63M | 864.00K | 2.17M | 1.66M | 1.13M |
| EBITDA | 50.94M | -33.23M | -42.35M | 10.89M | -19.83M | -17.98M | -15.56M | -10.78M | -6.06M | -2.39M | -752.00K |
| EBITDA Ratio | 2.83% | -2.76% | -3.99% | 1.16% | -2.91% | -3.33% | -4.26% | -4.71% | -4.83% | -2.83% | -1.36% |
| Operating Income | -17.30M | -69.17M | -65.70M | -866.00K | -33.45M | -28.73M | -19.20M | -11.64M | -8.82M | -4.05M | -1.88M |
| Operating Income Ratio | -0.96% | -5.74% | -6.20% | -0.09% | -4.77% | -5.32% | -6.76% | -6.56% | -7.02% | -4.78% | -3.40% |
| Total Other Income/Expenses | 2.95M | -14.95M | -12.19M | -15.07M | -8.74M | -5.86M | -2.21M | -9.32M | -1.68M | -826.00K | -839.00K |
| Income Before Tax | -14.35M | -84.12M | -77.88M | -15.93M | -42.18M | -34.59M | -21.40M | -20.96M | -10.50M | -4.87M | -2.72M |
| Income Before Tax Ratio | -0.80% | -6.98% | -7.35% | -1.65% | -6.02% | -6.41% | -7.54% | -11.82% | -8.36% | -5.76% | -4.91% |
| Income Tax Expense | -2.74M | -6.47M | -3.70M | 839.00K | -5.91M | -982.00K | -45.00K | -2.52M | 47.00K | 161.00K | 113.00K |
| Net Income | -12.04M | -77.65M | -74.19M | -16.77M | -36.27M | -33.61M | -21.36M | -18.45M | -10.55M | -5.04M | -2.83M |
| Net Income Ratio | -0.67% | -6.45% | -7.00% | -1.73% | -5.17% | -6.23% | -7.52% | -10.40% | -8.40% | -5.95% | -5.12% |
| EPS | -0.63 | -4.32 | -4.15 | -1.17 | -2.78 | -2.79 | -2.25 | -2.03 | -1.16 | -0.56 | -0.31 |
| EPS Diluted | -0.63 | -4.32 | -4.15 | -1.17 | -2.78 | -2.79 | -2.25 | -2.03 | -1.16 | -0.56 | -0.31 |
| Weighted Avg Shares Out | 19.24M | 17.98M | 17.88M | 14.38M | 13.06M | 12.05M | 9.50M | 9.07M | 9.07M | 9.07M | 9.07M |
| Weighted Avg Shares Out (Dil) | 19.24M | 17.98M | 17.88M | 14.38M | 13.06M | 12.05M | 9.50M | 9.07M | 9.07M | 9.07M | 9.07M |
CTP Builds 30,000 sqm of Distribution Space for Redcare Pharmacy, Europe's Leading Online Pharmacy
AMSTERDAM--(BUSINESS WIRE)--Regulatory News: CTP, Europe's largest listed developer, owner, and manager of industrial and logistics properties by gross lettable area (GLA), today began the construction of a new distribution centre of more than 30,000 sqm at CTPark Blatnice in the...
Redcare Pharmacy NV (SAEYY) Q3 2024 Earnings Call Transcript
Redcare Pharmacy NV (OTCPK:SAEYY) Q3 2024 Earnings Conference Call November 5, 2024 8:00 AM ET Company Participants Olaf Heinrich - CEO Jasper Eenhorst - CFO Conference Call Participants Christopher Yonen - HSBC Jan Koch - Deutsche Bank Olivier Calvet -...
Source: https://incomestatements.info
Category: Stock Reports